We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+15.27%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.3B
AUM Growth
+$1.38B
Cap. Flow
-$440M
Cap. Flow %
-2.54%
Top 10 Hldgs %
32.07%
Holding
728
New
61
Increased
216
Reduced
343
Closed
55

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$85M
2
ABT icon
Abbott
ABT
+$53.8M
3
EXC icon
Exelon
EXC
+$46.6M
4
BSX icon
Boston Scientific
BSX
+$42.6M
5
ABBV icon
AbbVie
ABBV
+$32.4M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$80.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.5M
3
CRWD icon
CrowdStrike
CRWD
+$45.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.6M
5
MRK icon
Merck
MRK
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 36.26%
2 Healthcare 22.78%
3 Financials 10.33%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EG icon
551
Everest Group
EG
$15.4B
$1.27M 0.01%
3,751
+297
+9% +$102K
CLX icon
552
Clorox
CLX
$11.8B
$1.27M 0.01%
10,581
-2,574
-20% -$343K
CHD icon
553
Church & Dwight Co
CHD
$23.4B
$1.27M 0.01%
13,180
-27,780
-68% -$2.74M
WST icon
554
West Pharmaceutical
WST
$23.3B
$1.26M 0.01%
5,770
-543
-9% -$116K
WY icon
555
Weyerhaeuser
WY
$17.2B
$1.25M 0.01%
48,802
-20,434
-30% -$535K
SJM icon
556
J.M. Smucker
SJM
$12.9B
$1.25M 0.01%
12,752
+1,663
+15% +$183K
RAL
557
Ralliant Corp
RAL
$7.82B
$1.25M 0.01%
+25,751
New +$1.27M
CNK icon
558
Cinemark Holdings
CNK
$3.93B
$1.24M 0.01%
+41,027
New +$1.24M
MAA icon
559
Mid-America Apartment Communities
MAA
$15.5B
$1.24M 0.01%
8,365
+245
+3% +$38.2K
BNS icon
560
Scotiabank
BNS
$106B
$1.23M 0.01%
22,262
-3,023
-12% -$154K
ZBH icon
561
Zimmer Biomet
ZBH
$17.8B
$1.21M 0.01%
13,302
-4,913
-27% -$475K
EL icon
562
Estee Lauder
EL
$30.1B
$1.17M 0.01%
14,497
-214
-1% -$13.8K
AGCO icon
563
AGCO
AGCO
$8.71B
$1.16M 0.01%
11,285
-680
-6% -$64.8K
SHOP icon
564
Shopify
SHOP
$165B
$1.15M 0.01%
10,007
-8,443
-46% -$844K
KGC icon
565
Kinross Gold
KGC
$28.6B
$1.15M 0.01%
73,495
+6,770
+10% +$98.5K
CDW icon
566
CDW
CDW
$17.6B
$1.13M 0.01%
6,328
-122
-2% -$20.7K
MOH icon
567
Molina Healthcare
MOH
$10.4B
$1.1M 0.01%
3,698
-599
-14% -$188K
AKAM icon
568
Akamai
AKAM
$16.4B
$1.08M 0.01%
13,517
-55,477
-80% -$4.31M
RDDT icon
569
Reddit
RDDT
$34.5B
$1.07M 0.01%
+7,086
New +$803K
HURN icon
570
Huron Consulting
HURN
$1.89B
$1.03M 0.01%
7,470
BRBR icon
571
BellRing Brands
BRBR
$1.52B
$1.02M 0.01%
17,688
GS icon
572
Goldman Sachs
GS
$309B
$1.02M 0.01%
1,442
-204
-12% -$118K
INVH icon
573
Invitation Homes
INVH
$17.6B
$1M 0.01%
30,553
+6,940
+29% +$233K
CF icon
574
CF Industries
CF
$18.4B
$984K 0.01%
10,695
-5,942
-36% -$506K
MAS icon
575
Masco
MAS
$16.4B
$965K 0.01%
14,990
-8,355
-36% -$526K

Similar funds

Candriam SCA's Q2 2025 Portfolio in Review

As of Q2 2025, Candriam SCA held 728 positions worth $17.3B, up 8.6% from $16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q2 2025 filing shows 61 new, 216 increased, 343 reduced and 55 closed positions. Its largest new stake was Tapestry: 260,834 shares worth $22.9M. The largest sale was Tesla, an estimated $80.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2025 buy was Tapestry: 260,834 shares worth $22.9M.
  • Candriam SCA added most to Broadcom in Q2 2025, an estimated $85M increase.
  • Candriam SCA's biggest Q2 2025 reduction was Tesla, cutting an estimated $80.5M.
  • Candriam SCA fully exited Banco Macro in Q2 2025, selling an estimated $17.6M.
  • Candriam SCA's ten largest holdings make up 32% of its $17.3B portfolio in Q2 2025.
  • Candriam SCA opened 61 new positions and closed 55 in Q2 2025.
  • Candriam SCA's portfolio value rose 8.6% quarter-over-quarter to $17.3B.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.